摘要
目的以甲磺酸双氢麦角毒碱片为对照，评价参七颗粒治疗瘀阻脑络型血管性痴呆的疗效。方法共观察瘀阻脑络型血管性痴呆231例，治疗组115例，给予口服参七颗粒；对照组116例，口服甲磺酸双氢麦角毒碱片。结果治疗组中医证侯积分、MMSE智能积分、ADL生活自理能力积分与对照组相似。部分单项症状体征的疗效优于对照组。凝血功能的改变显著优于对照组。结论参七颗粒可明显改善患者的临床症状，提高患者的生存质量。
Objective To investigate the curative effect of Sgenqikeli. Methods All the patients of vascular dementia （＂chidai＂ in TCM） came from the outpatienf of Yantai TCM Hospital,These patients were divided into two groups randomly, with 115 cases treated by Shenqi granule in therapeutic group, and the other 116 cases treated by Co-dergocrine Mesyiatc Tablets in control group. Both groups were treated for 12 weeks as a period of treatment. Results The two groups were similar in terms of the grade of TCM syndrome, the grade of MMSE intelligent and the grade of patients＇ self-care abifity. While the curative group excelled than the reference group in terms of single symptom or sign, such as the improvement of clotting action. Conclusions Shenqi granule can improve patients＇ clinical symptoms obviously and elevate patients＇ living quality.
出处
《国际中医中药杂志》
2008年第1期43-44,共2页
International Journal of Traditional Chinese Medicine
关键词
血管性痴呆
中医治疗
参七颗粒
Vascular dementia
TCM treatment
Shenqi granule
